meglumine has been researched along with Urticaria in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrillo-Martin, I; Gonzalez-Estrada, A; Kesler, AM; Rodriguez-Nava, G | 1 |
Auer, J; Braun, J; de Bucourt, M; Hamm, B; Heine, O; Pociej, J; Seithe, T; Vahldiek, J; Wolf, M; Wolny, D | 1 |
Bleicher, AG; Kanal, E | 1 |
Durmus, T; Hamm, B; Heine, O; Maurer, M; Wagner, M; Wolf, M | 1 |
4 other study(ies) available for meglumine and Urticaria
Article | Year |
---|---|
Gadolinium-induced anaphylaxis with positive skin test results.
Topics: Adult; Allergens; Anaphylaxis; Angioedema; Contrast Media; Diphenhydramine; Drug Hypersensitivity; Face; Female; Gadolinium; Histamine H1 Antagonists; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Skin Tests; Syncope; Urticaria | 2019 |
Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Deglutition Disorders; Early Detection of Cancer; Exanthema; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Product Surveillance, Postmarketing; Safety; Tachycardia; Urticaria; Young Adult | 2016 |
Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine.
Topics: Contrast Media; Dyspnea; Humans; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Pennsylvania; Risk Assessment; Risk Factors; Urticaria; Vomiting | 2008 |
Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: results in more than 84,000 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Comorbidity; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nausea; Organometallic Compounds; Prevalence; Risk Assessment; Risk Factors; Urticaria; Vomiting; Young Adult | 2012 |